Answers are grounded in this paper and cite their sources.
Use of a mild PIDA oxidation strategy to access heterocyclic (triazole, furoxan, furazan) fused pyridazine di- N -oxides.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: